HY-153219A-1mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
HY-153219A-10mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
HY-153219A-100mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
HY-153219A-25mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
HY-153219A-5mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
HY-153219A-50mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
HY-145835-1mg
|
MedChemexpress LLC
|
PERK-IN-5 [CAS 2616821-91-9]
|
|
Cancer-Kinase/protease
|
|
HY-145835-10mg
|
MedChemexpress LLC
|
PERK-IN-5 [CAS 2616821-91-9]
|
|
Cancer-Kinase/protease
|
|
HY-145835-100mg
|
MedChemexpress LLC
|
PERK-IN-5 [CAS 2616821-91-9]
|
|
Cancer-Kinase/protease
|
|
HY-145835-25mg
|
MedChemexpress LLC
|
PERK-IN-5 [CAS 2616821-91-9]
|
|
Cancer-Kinase/protease
|
|
HY-145835-5mg
|
MedChemexpress LLC
|
PERK-IN-5 [CAS 2616821-91-9]
|
|
Cancer-Kinase/protease
|
|
HY-145835-50mg
|
MedChemexpress LLC
|
PERK-IN-5 [CAS 2616821-91-9]
|
|
Cancer-Kinase/protease
|
|
HY-123076-10mg
|
MedChemexpress LLC
|
Pifithrin-Alpha, p-Nitro, Cyclic [CAS 60477-38-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-123076-100mg
|
MedChemexpress LLC
|
Pifithrin-Alpha, p-Nitro, Cyclic [CAS 60477-38-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-123076-25mg
|
MedChemexpress LLC
|
Pifithrin-Alpha, p-Nitro, Cyclic [CAS 60477-38-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-123076-5mg
|
MedChemexpress LLC
|
Pifithrin-Alpha, p-Nitro, Cyclic [CAS 60477-38-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-123076-50mg
|
MedChemexpress LLC
|
Pifithrin-Alpha, p-Nitro, Cyclic [CAS 60477-38-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-11018-10mg
|
MedChemexpress LLC
|
Risperidone [CAS 106266-06-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-11018-100mg
|
MedChemexpress LLC
|
Risperidone [CAS 106266-06-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-11018-5mg
|
MedChemexpress LLC
|
Risperidone [CAS 106266-06-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-11018-50mg
|
MedChemexpress LLC
|
Risperidone [CAS 106266-06-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-11018-1mL
|
MedChemexpress LLC
|
Risperidone [CAS 106266-06-2] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-135194-1mg
|
MedChemexpress LLC
|
Risperidone E-oxime [CAS 691007-09-7]
|
|
|
|
HY-100403-10mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
HY-100403-100mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|